Kinaxis Balance Sheet Health
Financial Health criteria checks 6/6
Kinaxis has a total shareholder equity of $415.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $706.1M and $290.8M respectively. Kinaxis's EBIT is $20.7M making its interest coverage ratio -1.7. It has cash and short-term investments of $294.6M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -1.7x |
Cash | US$294.63m |
Equity | US$415.30m |
Total liabilities | US$290.82m |
Total assets | US$706.12m |
Recent financial health updates
No updates
Recent updates
Kinaxis Inc. Just Beat EPS By 23%: Here's What Analysts Think Will Happen Next
Aug 02Kinaxis Inc.'s (TSE:KXS) Shares May Have Run Too Fast Too Soon
May 21An Intrinsic Calculation For Kinaxis Inc. (TSE:KXS) Suggests It's 42% Undervalued
May 01Kinaxis' (TSE:KXS) Returns On Capital Not Reflecting Well On The Business
Feb 29Kinaxis Inc.'s (TSE:KXS) Intrinsic Value Is Potentially 52% Above Its Share Price
Nov 20The Returns On Capital At Kinaxis (TSE:KXS) Don't Inspire Confidence
Nov 06At CA$154, Is It Time To Put Kinaxis Inc. (TSE:KXS) On Your Watch List?
Sep 22Kinaxis (TSE:KXS) Will Want To Turn Around Its Return Trends
Jul 30Estimating The Intrinsic Value Of Kinaxis Inc. (TSE:KXS)
Jul 15There Are Reasons To Feel Uneasy About Kinaxis' (TSE:KXS) Returns On Capital
Apr 19Calculating The Fair Value Of Kinaxis Inc. (TSE:KXS)
Mar 31Is It Time To Consider Buying Kinaxis Inc. (TSE:KXS)?
Feb 05Be Wary Of Kinaxis (TSE:KXS) And Its Returns On Capital
Jan 06Estimating The Intrinsic Value Of Kinaxis Inc. (TSE:KXS)
Dec 21Is Now An Opportune Moment To Examine Kinaxis Inc. (TSE:KXS)?
Oct 20Kinaxis Inc. (TSE:KXS) Shares Could Be 27% Below Their Intrinsic Value Estimate
Sep 17Financial Position Analysis
Short Term Liabilities: KXS's short term assets ($451.5M) exceed its short term liabilities ($239.4M).
Long Term Liabilities: KXS's short term assets ($451.5M) exceed its long term liabilities ($51.4M).
Debt to Equity History and Analysis
Debt Level: KXS is debt free.
Reducing Debt: KXS had no debt 5 years ago.
Debt Coverage: KXS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: KXS has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 02:19 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kinaxis Inc. is covered by 25 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Martin Toner | ATB Capital Markets |
Thanos Moschopoulos | BMO Capital Markets Equity Research |
Robert Young | Canaccord Genuity |